Workflow
LBX(603883)
icon
Search documents
老百姓: 2024年年度股东大会决议公告
Zheng Quan Zhi Xing· 2025-06-30 16:34
Meeting Details - The shareholders' meeting was held on June 30, 2025, at the company's conference room in Changsha, Hunan Province [1] - The meeting was attended by shareholders representing 50.8455% of the total shares [1] - Voting was conducted through a combination of on-site and online methods, and the meeting was presided over by Chairman Xie Zilong [1] Voting Results - All non-cumulative voting proposals were approved with high support, including: - Proposal 1: 99.9280% approval from A-shareholders [1] - Proposal 2: 99.9237% approval from A-shareholders [1] - Proposal 3: 99.9208% approval from A-shareholders [1] - Proposal 4: 99.9272% approval from A-shareholders [1] - The voting results indicate a strong consensus among shareholders for the proposed resolutions [2][3] Legal Compliance - The meeting's procedures were confirmed to comply with the Company Law and relevant regulations, ensuring the legality and validity of the meeting and voting results [4]
老百姓: 湖南启元律师事务所关于老百姓大药房连锁股份有限公司2024年年度股东大会的法律意见书
Zheng Quan Zhi Xing· 2025-06-30 16:34
Core Viewpoint - The legal opinion issued by Hunan Qiyuan Law Firm confirms the legality and validity of the procedures, participants, and voting results of the 2024 Annual General Meeting of the Company held on June 30, 2025 [1][10]. Group 1: Meeting Procedures - The notice for the meeting was announced on the Shanghai Stock Exchange website, detailing the time, location, method, agenda, and registration process [2][3]. - The meeting was held on June 30, 2025, at 15:30 in Changsha, Hunan Province [2]. Group 2: Participant Qualifications - A total of 6 shareholders and their proxies attended the meeting, representing 373,316,894 shares, which is 49.114% of the total shares [3][4]. - The qualifications of the attendees, including current directors, supervisors, and senior management, were verified as compliant with legal and regulatory requirements [4]. Group 3: Voting Procedures and Results - Voting was conducted through both on-site and online platforms, with specific time slots for each [3][5]. - The combined voting results showed overwhelming support for the proposals, with the majority of votes in favor, including 99.9280% for one proposal and 99.7944% for another [5][9]. - The voting results for minority investors also reflected strong support, with over 97% in favor for several proposals [6][8]. Group 4: Conclusion - The law firm concluded that the meeting's procedures, participant qualifications, and voting results were all in compliance with the relevant laws and regulations [10].
老百姓(603883) - 关于控股股东股票解押及再质押的公告
2025-06-30 11:00
证券代码:603883 证券简称:老百姓 公告编号:2025-031 老百姓大药房连锁股份有限公司 关于控股股东股票解押及再质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示: ●老百姓大药房连锁股份有限公司(以下简称"公司")控股股东老百姓医药集 团有限公司(以下简称"医药集团")持有公司股份数量为 191,729,175 股,占公司 总股本比例为 25.22%;累计质押股份数量为 118,950,000 股(含本次质押),占其所 持股份比例为 62.04%,占公司总股本比例为 15.65%。控股股东及一致行动人(医药集 团与陈秀兰)合计持有公司股份数量为 205,294,873 股,占公司总股本比例为 27.01%; 累计质押股份数量为 118,950,000 股(含本次质押),占其所持股份比例为 57.94%, 占公司总股本比例为 15.65%。 一、控股股东本次股份质押解除具体情况 公司于 2025 年 6 月 27 日获悉控股股东医药集团在中国证券登记结算有限责任公 司上海分公司办理了将质押给 ...
老百姓(603883) - 2024年年度股东大会决议公告
2025-06-30 11:00
证券代码:603883 证券简称:老百姓 公告编号:2025-032 重要内容提示: 本次会议是否有否决议案:无 一、 会议召开和出席情况 (一)股东大会召开的时间:2025 年 6 月 30 日 (二)股东大会召开的地点:湖南省长沙市开福区青竹湖路 808 号老百姓 15 楼会 议室 老百姓大药房连锁股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: | 1、出席会议的股东和代理人人数 | 342 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数(股) | 386,474,468 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例(%) | 50.8455 | (四)表决方式是否符合《公司法》及《公司章程》的规定,大会主持情况等。 本次会议采取现场投票和网络投票相结合的方式召开,老百姓大药房连锁股份有 限公司(以下简称"公司")董事会召集本次会议,本次 ...
老百姓(603883) - 湖南启元律师事务所关于老百姓大药房连锁股份有限公司2024年年度股东大会的法律意见书
2025-06-30 11:00
为出具本法律意见书,本所声明如下: 湖南启元律师事务所 关于老百姓大药房连锁股份有限公司 2024年年度股东大会的 法律意见书 二零二五年六月三十日 致:老百姓大药房连锁股份有限公司 湖南启元律师事务所(以下简称"本所")接受老百姓大药房连锁股份有限 公司(以下简称"公司")的委托,指派律师出席了公司 2024 年年度股东大会(以 下简称"本次股东大会"),对本次股东大会的召集和召开程序、出席会议人员 及召集人的资格、表决程序和表决结果的合法有效性进行律师见证,并发表本法 律意见。 本所根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华 人民共和国证券法》(以下简称"《证券法》")、《上市公司股东会规则》(以 下简称"《股东会规则》")等我国现行法律、法规、规范性文件以及《老百姓 大药房连锁股份有限公司章程》(以下简称"《公司章程》")的有关规定出具 本法律意见书。 (一)本所出具本法律意见书是基于公司已承诺所有提供给本所的文件的正 本以及经本所查验与正本保持一致的副本均为真实、完整、可靠,无隐瞒、虚假 或重大遗漏之处。 (二)本所遵循了勤勉尽责和诚实信用原则,严格履行了法定职责,对本法 律意见书 ...
储蓄存款增加,真实原因不是老百姓不敢消费,而是另有玄机
Sou Hu Cai Jing· 2025-06-30 02:57
Core Viewpoint - The explosive growth of household savings in China since 2022 is attributed to multiple underlying factors rather than simply a reluctance to consume [1][8]. Group 1: Savings Growth - By September 2022, the total household savings reached an unprecedented 115.7 trillion yuan, with an increase of 13.21 trillion yuan in the first three quarters of 2022 compared to only 8.49 trillion yuan in the same period of 2021, marking a year-on-year increase of 4.72 trillion yuan [1]. - Despite a general decline in consumption, the savings continue to rise, indicating that the situation is influenced by more than just consumer sentiment [3][8]. Group 2: Factors Influencing Savings - The repeated COVID-19 outbreaks and extensive lockdown measures have severely restricted residents' mobility and consumption, leading to a significant decline in offline spending [5]. - Increased risk awareness due to the pandemic has prompted residents to prioritize savings for potential future uncertainties, such as unemployment or health issues, viewing savings as a "lifeline" [5][6]. - The cooling real estate market has shifted investment behaviors, with many individuals postponing or abandoning home purchases, leading to increased deposits as funds originally earmarked for down payments are saved instead [5][6]. Group 3: Investment Channels - The lack of safe and reliable investment options has contributed to the rise in savings, as high-risk stock market investments and declining returns from mutual funds have discouraged residents from investing [6]. - With bank deposit interest rates remaining low, saving in banks has become a relatively safer option compared to the risks associated with other investment avenues [6][8]. Group 4: Policy Recommendations - Simply lowering deposit interest rates may not effectively stimulate consumption; a more comprehensive set of policy measures is needed to enhance consumer confidence and promote economic recovery [3][8].
茅台神话碎了!1499元敞开卖,经销商哭了老百姓笑了
Sou Hu Cai Jing· 2025-06-28 14:30
Core Viewpoint - The price of Moutai, once considered a luxury item, has significantly decreased, allowing consumers to purchase it at its original price of 1499 yuan, marking a shift in the market dynamics of the liquor industry [1][5][10]. Price Trends - In 2021, Moutai's market price soared to over 3000 yuan, with consumers often needing to rely on luck or connections to purchase it at retail price [3][5]. - Since late last year, Moutai's price has been on a downward trend, dropping from over 2800 yuan to 1499 yuan, with increased availability on e-commerce platforms [5][8]. Market Dynamics - The decline in Moutai's price is attributed to several factors, including reduced consumer spending on luxury items due to economic conditions, increased supply from the manufacturer, and a decrease in demand from public spending [5][6]. - Moutai's previous high prices were driven by its status as a social currency in China, but this bubble has burst as economic realities set in [6][9]. Industry Implications - Moutai's price reduction is expected to impact the entire liquor industry, as other high-end brands like Wuliangye and Guojiao may also need to lower their prices to remain competitive [8][9]. - The shift in pricing strategy may force liquor companies to focus more on quality, service, and value rather than relying on price increases for profitability [9][10]. Consumer Behavior - The price drop may change younger consumers' perceptions of liquor, making it more accessible and potentially increasing its consumption among this demographic [9][11]. - The return to a more reasonable price point for Moutai and other liquors could signal a broader market correction, moving away from speculative pricing [10][11].
前三季度存款增加13万亿,老百姓都不愿消费了?原因终于找到了
Sou Hu Cai Jing· 2025-06-25 04:55
Core Insights - The surge in Chinese household deposits reached 13.21 trillion yuan in the first three quarters of 2022, a significant increase of 4.72 trillion yuan compared to the same period last year, totaling an astonishing 22.77 trillion yuan in deposit growth. This contrasts sharply with a mere 35.3% household consumption rate, significantly lower than the international average of 60% [1][8]. Group 1: Factors Influencing Deposit Surge - The ongoing pandemic and economic downturn have heightened uncertainty about the future, leading individuals to prioritize savings as a risk management strategy. Many lost their income during lockdowns, realizing the importance of savings [3]. - The sluggish real estate market has also significantly impacted household deposits. The decline in housing demand due to economic pessimism has led families to postpone home purchases, with many cities experiencing a drop in housing prices to levels not seen in three to five years [3][4]. - A lack of safe and reliable investment channels has contributed to the increase in deposits. The stock market's volatility and poor performance of mutual funds have discouraged investment, making bank deposits a relatively safer option despite declining interest rates [6][8]. Group 2: Economic Context - The Chinese economy faced numerous challenges in 2022, including repeated pandemic disruptions that severely affected consumer markets. Strict lockdown measures led to a halt in offline consumption, with online shopping unable to compensate for the loss [4]. - Government support provided only basic necessities, forcing consumers to cut back on non-essential spending, further contributing to the increase in savings [4].
“能为老百姓冲锋在前,我特别骄傲”(时空对话)
Ren Min Ri Bao· 2025-06-24 22:01
Core Points - The article highlights the life and experiences of Li Shijie, a 102-year-old veteran who participated in the Anti-Japanese War and the Liberation War, emphasizing his dedication and sacrifices for the country [3][4][5]. Group 1: Historical Context - Li Shijie was born in September 1922 in Heze, Shandong, and began participating in revolutionary activities at the age of 15, joining the Communist Party at 17 [3]. - He actively fought in various battles from 1937 onwards, including the Anti-Japanese War and the Liberation War, and settled in Guizhou after 1949 [3][4]. Group 2: Personal Experiences - Li recalls the harsh conditions during the war, including a lack of equipment and resources, yet he and his fellow militia members managed to conduct guerrilla warfare effectively [4][5]. - He experienced significant injuries during combat, including a bullet wound to his leg, which left him with a permanent disability [4][5]. Group 3: Community Support - Li emphasizes the importance of support from the local population, stating that the people's backing was crucial for their success in the war [5]. - His unit maintained strict discipline and built strong relationships with the local communities, ensuring they did not exploit the villagers [5]. Group 4: Post-War Contributions - After the war, Li Shijie contributed to local development in Guizhou, serving in various governmental roles, including as the head of the publicity department [6]. - He was involved in significant projects like the Hongfeng Hydropower Station, which continues to serve essential functions today [6]. Group 5: Legacy and Education - Li Shijie actively shares his war stories with his children and emphasizes the importance of remembering history, stating that today's peace is a result of past sacrifices [7]. - His family continues to honor his legacy by documenting and sharing his experiences, ensuring that the history of the Anti-Japanese War is not forgotten [7].
守好老百姓的“看病钱”“救命钱” 国家医保局印发通知
Yang Shi Xin Wen· 2025-06-24 16:33
Core Viewpoint - The National Healthcare Security Administration has issued a notice to strengthen the management of designated medical institutions under the medical insurance system, emphasizing strict supervision of medical insurance funds to ensure the quality of healthcare services and protect patients' rights [1]. Group 1: Regulations for Designated Medical Institutions - Medical institutions applying to become designated under the insurance scheme must use drug and consumable traceability codes, ensuring comprehensive collection and payment based on these codes [2]. - Designated public medical institutions must adhere to government-guided pricing for basic medical services, while non-public institutions must commit to the same pricing standards and principles of fairness and quality [2]. - A six-month policy guidance period is established for newly designated institutions to comply with insurance management and payment policies, with penalties for violations during this period [2]. Group 2: Patient Rights and Service Standards - It is strictly prohibited to force patients to purchase drugs or consumables outside the institution or to discharge them prematurely based on insurance policies [5]. - Designated public medical institutions are required to procure drugs and consumables through provincial centralized procurement platforms, ensuring compliance with traceability codes [5]. - Institutions must provide necessary prescription services for drugs that are temporarily unavailable, ensuring smooth electronic prescription processes [5]. Group 3: Monitoring and Exit Mechanisms - The notice mandates enhanced monitoring of hospitalization behaviors for vulnerable groups, including those with chronic or special diseases, to ensure timely provision of insurance services [8]. - A robust exit mechanism for designated medical institutions is required, with strict penalties for fraudulent activities or failure to comply with documentation requirements [8]. - The management of healthcare professionals involved in insurance fund usage will be strengthened through a point-based system, leading to potential penalties for those accumulating excessive points [8].